✦ LIBER ✦

Cancer-Associated Glycosphingolipid Antigens: Their Structure, Organization, and Function

✍ Scribed by Hakomori, Sen-itiroh

Book ID: 120835067
Publisher: S. Karger AG
Year: 1998
Tongue: English
Weight: 133 KB
Volume: 161
Category: Article
ISSN: 1422-6405
DOI: 10.1159/000046451

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure and function of mitochondria:

Structure and function of mitochondria: Their organization and disorders

✍ Ozawa, Takayuki; Tanaka, Masashi; Suzuki, Hiroshi; Nishikimi, Morimitsu 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 893 KB

Transplantation antigens of class II, st

Transplantation antigens of class II, structure, function, and their monoclonal antibodies

✍ G. Egert 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 133 KB

The transporter associated with antigen

The transporter associated with antigen processing TAP: structure and function

✍ Brigitte Lankat-Buttgereit; Robert Tampé 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Structure-function analysis of muscarini

Structure-function analysis of muscarinic receptors and their associated G proteins

✍ Evi Kostenis; Fu-Yue Zeng; Jürgen Wess 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 733 KB

Chemical structure and function of glyco

Chemical structure and function of glycosphingolipids ofSphingomonasspp and their distribution among members of the α-4 subclass ofProteobacteria

✍ K Kawahara; H Kuraishi; U Zähringer 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 98 KB

Clonal variation and functional correlat

Clonal variation and functional correlation of organ-specific metastasis and an organ-specific metastasis-associated antigen

✍ P. J. Shearman; B. M. Longenecker 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 French ⚖ 887 KB

## Abstract Monoclonal antibodies were used to probe the cell surface of organ‐selected metastatic variant cells. Previously we defined a liver metastasis‐associated antigen (LMAA) by means of the reaction of a monoclonal antibody with a liver metastasis selected tumour variant cell line, MDCC‐AL2.